In a recent study posted to the medRxiv* preprint server, researchers estimated the effectiveness of monovalent messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccines against ...

Ugur Sahin, M.D., Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel ...

In a recent study published in the journal Cell, researchers evaluated the protection conferred by booster doses of the preclinical version of the Moderna messenger ribonucleic acid (mRNA)-1273 ...

Foundation-funded project targets infectious bronchitis and infectious laryngotracheitis viruses.

Vaccines using mRNA, or messenger ribonucleic acid, are on the rise in the fight against the coronavirus pandemic. The technology has yielded encouraging results, but a successful mRNA vaccine has ...

Messenger RNA, or mRNA, is genetic material that tells your body how to make proteins. In an email, Stuart Ray, M.D., a professor at Johns Hopkins School of Medicine, told VERIFY that “mRNA is a ...

Scientists say they have developed a nanoparticle -- an extremely tiny biodegradable container -- that has the potential to improve the delivery of messenger ribonucleic acid (mRNA)-based vaccines for ...

This year, the public was introduced to messenger ribonucleic acid, or mRNA, when it became a hero in the worldwide race to develop COVID-19 vaccines. Scientists lab-engineered mRNA to instruct human ...